InvestorsHub Logo

laser777

02/21/20 1:27 PM

#266481 RE: hyperopia #266452

Hyperopia,
I agree wholeheartedly with this thinking.
It is probably the best option for patients also.
Merck would bring this to market a lot faster than NWBO.